TAK-700 – No competitive edge against Zytiga Generics; while in early setting competition is also heating up! In the recent past, treatment paradigm of metastatic prostate cancer (mPC) has witnessed
Merck -Suvorexant delayed but no additional studies required is a sigh of relief
Date:
2015-07
MORE PUBLICATIONS
Merck -Suvorexant delayed but no additional studies required is a sigh of relief
US$ 90 2015-07 Pages: 1Categories
- Automotive
- Bearings
- Business Services
- Chemicals and Materials
- Coatings
- Company Profiles
- Consumer Goods
- Defense
- Electronics
- Energy
- Financial Services
- Food & Beverages
- Manufacturing & Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Public Sector
- Resins
- Technology
- Telecommunications and Wireless
- Vacuum Products
Popular Articles
- Global Pipe Coiler (Pipe Winder) Market Report and Forecast to 2021 (Special)
- Global Energy Drink Market Will Grow At A CAGR Of Approximately 8.6%
- Global Disposable Diapers Market Analysis
- Trade Me Group Limited : Company Profile and SWOT Analysis
- Mayo Clinic – Strategic SWOT Analysis Review
- Global Automotive Radiator Market Projected To Register CAGR Of 5.9% Between 2016 And 2020
- USA Dominated Disposable ECG Electrode Market
- Global Air Freshener Gel Market Worth $ 150 Million by 2018
- Global Natural Waxes Market Worth $ 6.38 Billion by 2019
- Global Densitometer Market Worth $ 464 Million by 2018
